Works about LAMIVUDINE


Results: 1086
    1
    2
    3
    4
    5
    6
    7
    8

    Adding adefovir vs. switching to entecavir for lamivudine-resistant chronic hepatitis B ( ACE study): a 2-year follow-up randomized controlled trial.

    Published in:
    Liver International, 2013, v. 33, n. 2, p. 244, doi. 10.1111/liv.12036
    By:
    • Yim, Hyung Joon;
    • Seo, Yeon Seok;
    • Yoon, Eileen L.;
    • Kim, Chang Wook;
    • Lee, Chang Don;
    • Park, Sang Hoon;
    • Lee, Myung Seok;
    • Park, Choong Kee;
    • Chae, Hee Bok;
    • Kim, Moon Young;
    • Baik, Soon Koo;
    • Kim, Yun Soo;
    • Kim, Ju Hyun;
    • Lee, Jung Il;
    • Lee, Jin Woo;
    • Hong, Sun Pyo;
    • Um, Soon Ho
    Publication type:
    Article
    9
    10
    11
    12
    13
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31

    Mitochondrial DNA Parameters in Blood of Infants Receiving Lopinavir/Ritonavir or Lamivudine Prophylaxis to Prevent Breastfeeding Transmission of HIV-1.

    Published in:
    Journal of Clinical Medicine, 2020, v. 9, n. 9, p. 2972, doi. 10.3390/jcm9092972
    By:
    • Monnin, Audrey;
    • Nagot, Nicolas;
    • Periès, Marianne;
    • Vallo, Roselyne;
    • Meda, Nicolas;
    • Singata-Madliki, Mandisa;
    • Tumwine, James K.;
    • Kankasa, Chipepo;
    • Ngandu, Nobubelo;
    • Goga, Ameena;
    • Reynier, Pascal;
    • Tylleskär, Thorkild;
    • Van de Perre, Philippe;
    • Molès, Jean-Pierre
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38

    Steady-state pharmacokinetics of lamivudine in end-stage kidney failure persons with detectable and undetectable HIV-1 RNA in peritoneal dialysis effluent.

    Published in:
    European Journal of Medical Research, 2024, v. 29, n. 1, p. 1, doi. 10.1186/s40001-024-01972-8
    By:
    • Mooko, Teboho;
    • Bisiwe, Feziwe Busiswa;
    • Mondleki, Enkosi;
    • Morobadi, Molefi Daniel;
    • Chikobvu, Perpetual;
    • Nyaga, Martin Munene;
    • Bala, Asis;
    • Goedhals, Dominique;
    • Mofokeng, Thabiso Rafaki Petrus;
    • Kemp, Gabre;
    • Ndlovu, Kwazi Celani Zwakele
    Publication type:
    Article
    39

    Patient-Reported Outcomes After Switching to a 2-Drug Regimen of Fixed-Dose Combination Dolutegravir/Lamivudine: 48-Week Results from the SALSA Study.

    Published in:
    AIDS & Behavior, 2025, v. 29, n. 1, p. 235, doi. 10.1007/s10461-024-04479-9
    By:
    • Kumar, Princy;
    • Clarke, Amanda E.;
    • Jonsson-Oldenbüttel, Celia;
    • Deltoro, Miguel García;
    • Di Giambenedetto, Simona;
    • Brites, Carlos;
    • Hocqueloux, Laurent;
    • Lu, Po-Liang;
    • Oyee, James;
    • Oglesby, Alan;
    • Wynne, Brian;
    • Jones, Bryn;
    • Evitt, Lee A.;
    • Fox, Dainielle;
    • Kisare, Michelle;
    • Priest, Julie
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50